Tailored Therapy to Hemodynamic Goals for Advanced Heart Failure
Author:
- 1 August 1999
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 1 (3) , 251-257
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Inotropic Therapy for Heart FailureNew England Journal of Medicine, 1998
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureNew England Journal of Medicine, 1998
- Improving survival for patients with advanced heart failure: A study of 737 consecutive patientsJACC, 1995
- Treatment of Congestive Heart Failure and Cheyne-Stokes Respiration during Sleep by Continuous Positive Airway PressureAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failureJACC, 1994
- Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).Circulation, 1993
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 1990
- Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1989
- Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure.Circulation, 1986